falsefalse

Post-Conference Perspectives: Updates in Colorectal Cancer: Highlights from ASCO GI 2023 and Beyond - Episode 3

MOUNTAINEER-03 Clinical Trial Study Design and Implications

Clinical insights regarding the design, patient population, and overall aims of the ongoing phase 3 clinical trial MOUNTAINEER-03.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
    EP. 1: An Introduction to Biomarker Testing in Metastatic Colorectal Cancer
    EP. 2: Clinical Trial Review: MOUNTAINEER
    Now Viewing
    EP. 3: MOUNTAINEER-03 Clinical Trial Study Design and Implications
    EP. 4: Emerging Treatment Options for Patients with HER2+ Metastatic Colorectal Cancer
    EP. 5: The Future of the Metastatic Colorectal Cancer Treatment Landscape

    Related Content:

    Post-Conference Perspectives: Updates in Colorectal Cancer: Highlights from ASCO GI 2023 and BeyondOncLive News Network®
    Novel Treatment Approaches Under Investigation in ROS1+ NSCLC
    Another FDA-Approved Option? The Potential Role for Taletrectinib in ROS1+ NSCLC
    Pooled Data for Taletrectinib in ROS1+ NSCLC
    x